Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1565822-20-9
Purity
95%
PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to crizotinib.
Properties
Name
PF-06439015 Methanesulfonate
Smiles
CS(=O)(=O)O.CC=1N=C(SC1C=2C=NC(N)=C(C2)O[C@H](C)C=3C=C(F)C=CC3N4N=CC=N4)[C@](C)(O)CO
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
PF-06439015 | crizotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$241
2 mg
$361
5 mg
$722
10 mg
$1250
15 mg
$1515
20 mg
$1779
25 mg
$2164
30 mg
$2549
35 mg
$2933
40 mg
$3318
45 mg
$3558
50 mg
$3799
75 mg
$5049
100 mg
$POA
Quantity
1
Total amount
$ 722
PF-06439015 | crizotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.